A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
It is distinct from Rybelsus, which is also oral semaglutide but is licensed at lower doses (3 mg, 7 mg, 14 mg) for type 2 diabetes rather than weight loss
This matters for managing side effects, planning surgeries (GLP-1 agonists can cause aspiration risk under anesthesia due to delayed gastric emptying), and understanding the timeline for return of appetite after stopping weight-loss medications
For some, its been a literal lifesaver and for others, there have been issues that kept them from staying on them long-term
GH vs IGF-1 IGF-1 production depends upon the availability of growth hormone and the function of the pituitary gland and the liver
While metabolic changes may contribute, the effectiveness of a Wegovy pen should always be assessed through consistent weight loss and clinical progress rather than side effects alone